US-based Memorial Sloan Kettering Cancer Center (MSKCC) has launched MSKCC India to provide cancer patients in India with access to the institution's world-renowned oncologists, research, clinical trials, and education. The effort stems from the institution's core mission of advancing transformative cancer care through education and research worldwide. 

MSKCC India will open a physical location in Chennai, centrally located for patients and staff members. The location will serve as a hub for medical staff who will help patients coordinate written or virtual consultations, and they will be able to communicate in English, Hindi, Urdu, Tamil, Telugu and Kannada.

If necessary, employees will also be able to collect medical records from patients' homes, making the process more convenient for those utilising this service. Patients across India will be able to obtain a remote opinion from experts at Memorial Sloan Kettering Cancer Center in the comfort of their home or any Internet-enabled location without travelling to MSKCC India in Chennai.

As part of this first-of-its-kind offering, MSKCC India will provide remote opinions via video or written consultations. 

Specific services include: Pathology diagnosis, radiology scan reviews Next-generation sequencing (MSK-IMPACTTM) of a patient's tumour and treatment recommendations and travel assistance to New York City.

As part of this effort to bring world-class care to people in India diagnosed with cancer, Memorial Sloan Kettering Cancer Center has partnered with Coimbatore-based iCliniq. This partnership is the first-of-its-kind for both iCliniq and Memorial Sloan Kettering Cancer Center.